Monitoring of disease progression by bioluminescence imaging and magnetic resonance imaging in an animal model of hematologic malignancy

Overriding Imatinib Resistance with a Novel ABL Kinase Inhibitor

Neil P. Shah, Chris Tran, Francis Y. Lee et al. · Science · 2004 · 1.8K citations

Medicine, Oncology, Pharmacology +14

Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl

Ellen Weisberg, Paul W. Manley, Werner Breitenstein et al. · Cancer Cell · 2005 · 1.5K citations · Full text

Pharmacy, Medicinal Chemistry, Molecular Biology +6

In vivo imaging of light-emitting probes

Brad Rice, M. D. Cable, Michael Nelson · Journal of Biomedical Optics · 2001 · 498 citations

Engineering, Bioengineering, Biomedical Engineering +17

The P190, P210, and P230 Forms of the <i>BCR/ABL</i> Oncogene Induce a Similar Chronic Myeloid Leukemia–like Syndrome in Mice but Have Different Lymphoid Leukemogenic Activity

Shaoguang Li, Robert Ilaria, Ryan P. Million et al. · The Journal of Experimental Medicine · 1999 · 494 citations · Full text

Medicine, Molecular Biology, Oncology +10

Rapid and Quantitative Assessment of Cancer Treatment Response Using In Vivo Bioluminescence Imaging

Alnawaz Rehemtulla, Lauren D. Stegman, Shaun Cardozo et al. · Neoplasia · 2000 · 465 citations · Full text

Medicine, Cancer Biology, Oncology +16